Swissmedic Document on the Role of the RP in Contract Manufacturing
The Swiss authority Swissmedic has published a new auxiliary document. This document is intended to clarify which documents should be submitted as part of an authorisation application with type IA/IAIN variations, type IB variations, type II variations in order to demonstrate compliance with GMP regulations of foreign manufacturers of APIs and/or medicinal products. This verification is the responsibility of the Responsible Person (RP).
The document is intended for marketing authorisation holders or applicants for marketing authorisation of ready-to-use medicinal products manufactured abroad and/or in Switzerland and containing APIs from foreign manufacturers.
The RP is responsible for checking the GMP conformity of the manufacturers on a regular basis. Documents such as GMP certificates, audit reports, inspection reports and Site Master Files, etc. - which are taken into account in such reviews - can be requested from Swissmedic at any time and / or checked during inspections.
For this purpose, there is the so-called "Declaration by the Responsible Person for foreign manufacturers HMV4" (RP Declaration). In this declaration, the RP confirms the GMP conformity of the manufacturer on the basis of an audit carried out by the marketing authorisation holder or by a third party commissioned by the marketing authorisation holder and on the basis of the documents mentioned above.
What has to be submitted additionally is listed in detail in the document "Guidance document GMP compliance by foreign manufacturers HMV4".
Related GMP News
20.08.2025What is the FDA Post-Warning Letter Meeting?
20.08.2025European Pharmacopoeia: New Online-only Platform
20.08.2025Events in an Audit Trail and Determination of GMP-Relevant Data in the Audit Trail
20.08.2025The Importance of Knowledge Management in GMP
13.08.2025FDA assesses economic Benefits of investing in Quality Management
13.08.2025How to Deal with Audit Trails in Preconfigured Equipment?